avance nerve graft Purple Book BLA 125816
- BLA number
- 125816
- Proprietary names
- avance nerve graft
- Proper names
- acellular nerve allograft-arwx
- Applicant
- Axogen Corporation
- Center
- CBER
- First observed release
- 2025-12-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | avance nerve graft | acellular nerve allograft-arwx | 351(a) | 1•LENGTHS: 15 MM, 30 MM, 50 MM, AND 70 MM •DIAMETERS: 1 TO 2 MM, 2 TO 3 MM, 3 | Implant | Implantation | Pouch | Rx | Licensed | 2025-12-03 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2026-04-01 | U | 001 | avance nerve graft | 351(a) | Rx | Axogen Corporation |
| 2025-12-01 | N | 001 | avance nerve graft | 351(a) | Rx | Axogen Corporation |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2025-12-01 | 001 | avance nerve graft | 351(a) | Rx | Licensed | 2025-12-03 |